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Generation of structurally novel 
short carotenoids and study of their 
biological activity
Se H. Kim1, Moon S. Kim2, Bun Y. Lee2 & Pyung C. Lee2
Recent research interest in phytochemicals has consistently driven the efforts in the metabolic 
engineering field toward microbial production of various carotenoids. In spite of systematic studies, 
the possibility of using C30 carotenoids as biologically functional compounds has not been explored 
thus far. Here, we generated 13 novel structures of C30 carotenoids and one C35 carotenoid, including 
acyclic, monocyclic, and bicyclic structures, through directed evolution and combinatorial biosynthesis, 
in Escherichia coli. Measurement of radical scavenging activity of various C30 carotenoid structures 
revealed that acyclic C30 carotenoids showed higher radical scavenging activity than did DL-α-
tocopherol. We could assume high potential biological activity of the novel structures of C30 carotenoids 
as well, based on the neuronal differentiation activity observed for the monocyclic C30 carotenoid 
4,4′-diapotorulene on rat bone marrow mesenchymal stem cells. Our results demonstrate that a series 
of structurally novel carotenoids possessing biologically beneficial properties can be synthesized in E. 
coli.
Isoprenoids and their derivatives such as sterols, terpenes, dolichols, quinines, etc. are the most abundant class of 
secondary metabolites with diverse functions in microbial, plant, and animal metabolism1. The building block of 
isoprenoid derivative compounds is isopentenyl diphosphate (IPP), which is synthesized via two non-homologous 
pathways: the mevalonate pathway and the 1-deoxy-d-xylulose 5-phosphate/2-C-methyl-d-erythritol 
4-phosphate (DOXP/MEP) pathway2,3. Terpenoids and carotenoids are the most industrially important isopre-
noid derivatives that are used as cosmeceuticals, flavors, colorants, and pharmaceutical compounds.
Many efforts for microbial production of valuable compounds including isoprenoids and polyketides have 
been made using metabolic engineering4–7. Most of these studies have focused on providing an improved pool of 
precursors such as IPP in heterologous hosts including E. coli and yeasts. More recent studies have focused on the 
optimization of metabolic flux for enhanced target production to avoid accumulation of harmful intermediates 
and control rate-limiting steps in the heterologous host8. To this end, synthetic and systems biology approaches 
have been adapted to control pathway enzymes at both the transcriptional and translational levels with synthetic 
biological parts including engineered promoters, ribosome binding sites, and genetic circuits9,10.
Carotenoids are derivatives of isoprenoids that play diverse roles in nature11. Thus far, more than 700 carote-
noids have been isolated and identified12. Carotenoids gained considerable research attention in the past owing to 
their usability as natural pigments; however, their high antioxidative and anticarcinogenic activities and potential 
use as cosmeceutical or pharmaceutical compounds have only been revealed more recently13–16. Animals obtain 
carotenoids through their diet, via consumption of fruits and vegetables. After oxidative cleavage of the dietary 
carotenoids (including xanthins), the bioactive cleavage products, such as apocarotenoids, are used in retinal for-
mation and transcription system activation17. In addition, apocarotenoids are known to act as anticancer agents 
and cellular modulators of the retinoic acid receptors, retinoid X receptors, peroxisome proliferator-activated 
receptors, and estrogen receptors17. In a recent study, we proposed an anticancer mechanism of two major carot-
enoids, crocin and crocetin, found in the dried, dark red stigmas of Crocus sativus, which has been traditionally 
used since ancient times in Southwest Asia for the treatment of some diseases and as a flavoring and coloring 
agent18. These two carotenoids are C20 structures generated by the cleavage of C40 carotenoids, the most abundant 
carotenoid structures in nature including lycopene, β -carotene, and astaxanthin. Some bacteria produce C50 or 
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C30 carotenoids; however, these are structurally less diverse than the C40 carotenoids. Until date, only few C30 
carotenoid-producing natural sources are known, including Staphylococcus aureus, Methylomonas sp. 16a, and 
some strains of the genus Bacillus19–22.
Several studies successfully discovered novel carotenoids by applying a combinatorial biosynthesis approach 
with in vitro evolved carotenogenic enzymes23–27. In vitro evolution of key enzymes, which determine the struc-
ture of carotenoid in the early step, has led generation of novel series of carotenoids in E. coli23–27. Recently, 
Furubayashi and coworkers created non-natural C50 carotenoids through the assembly of moderately selective 
enzymes engineered by directed evolution in E. coli28. Enzymes commonly show strict substrate specificity; how-
ever, carotenogenic enzymes show relatively promiscuous substrate specificity giving rise to novel carotenoid 
structures in a heterologous host29. Phytoene synthase (CrtB), phytoene desaturase (CrtI), lycopene cyclase 
(CrtY), 4,4′ -diapophytoene synthase (CrtM), and 4,4′ -diapophytoene desaturase (CrtN) were evolved in vitro, 
allowing the biosynthesis of diverse carotenoids in E. coli30. Although extensive work has been performed on the 
diversification and identification of carotenoid structures, the existence of cyclic C30 carotenoids in nature has not 
been reported; 4,4′ -diapotorulene was the first reported monocyclic C30 carotenoid structure biosynthesized by 
metabolically engineered E. coli23.
In this study, we created 13 structurally novel C30 carotenoids, including acyclic, monocyclic, and bicyclic 
structures, and one novel C35 carotenoid, through combinatorial biosynthesis with natural carotenoid bio-
synthetic enzymes from various microorganisms and the evolved enzymes, CrtN and CrtY, in E. coli (Fig. 1). 
Furthermore, we assayed the 2,2-diphenyl-1-picrylhydrazyl (DPPH)-scavenging and neuronal differentiative 
activities of the C30 carotenoids on rat bone marrow mesenchymal stem cells to explore their potential as bioac-
tive compounds.
Results
Biosynthesis of structurally novel acyclic C30 carotenoids and a C35 carotenoid. Previously, CrtN 
mutant clones obtained by directed evolution showed altered desaturation activity in E. coli30. Similarly, we con-
structed a CrtN mutant library by error-prone PCR upon expression of the substrate, 4,4′ -diapophytoene, in 
E. coli. We screened clones based on the color change to dark reddish, yellowish, and pale-yellowish colonies, 
depending on the number of conjugated double bonds (CDBs) in the chromophore of the carotene backbone, as 
compared to the reddish wild-type colonies. Their carotenoid profiles were monitored by HPLC to select CrtNr, 
CrtNy, and CrtNz mutant clones showing increased pathway selectivity for 4,4′ -diapolycopene, 4,4′ -diaponeuro-
sporene, and 4,4′ -diapo-ζ -carotene, respectively (peaks 1, 2, and 3 in Fig. 2a). Unfortunately, we failed to deter-
mine the structure of the CrtN mutants due to the lack of CrtN structural data, even though we performed 
site-directed mutagenesis (Supplementary Fig. S1) and docking prediction analysis.
In an attempt to create novel carotenoid structures, we first extended the wild-type 4,4′ -diapolycopene 
pathway (pACM-MSA-NSA) using two wild-type enzymes, C40 spheroidene monooxygenase (CrtARC) and C40 
1-hydroxycarotenoid 3,4-desaturase (CrtDRC) from Rhodobacter capsulatus, resulting in the generation of two 
new peaks in the HPLC profile (peaks 4 and 5 in Fig. 2b). Based on combined analysis of retention time, UV/Vis 
absorption, and mass spectra, peaks 4 and 5 were assigned to the acyclic C30 carotenoids 4,4′ -diaponeurosporen-
6,6′ -dione and 4,4′ -diapoplycopene-6,6′ -dione, respectively (Fig. 2b). Especially, the broadened UV/Vis absorp-
tion spectrum and longer λ max (467 nm) observed for the compound of peak 5 supported the presence of 11 fully 
CDBs and two ketone groups in its structure31.
Figure 1. Carotenoid biosynthesis pathway diversified through E. coli. Each structure was classified.
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Next, the 4,4′ -diapolycopene pathway was extended with C50 lycopene elongase (CrtEb), which was cloned 
from Corynebacterium glutamicum. CrtEb catalyzes the sequential addition of two IPPs into the natural sub-
strate lycopene to produce C45 nonaflavuxanthin and C50 flavuxanthin. Extension of the 4,4′ -diapolycopene path-
way with CrtEb resulted in the production of an elongated acyclic C35 carotenoid, 4,4′ -diapononaflavuxanthin 
(peak 6 in Fig. 2c), assigned on the basis of combined structural analysis as described above.
Biosynthesis of structurally novel cyclic C30 carotenoids. Next, we aimed to create cyclic C30 carote-
noids by introducing various bacterial C40 lycopene cyclases (CrtY) into the redesigned C30 carotenoid biosynthesis 
pathways. As β -ionone ring formation in C30 carotenoids requires the saturated C4-C5 and C4′ -C5′ bonds of a car-
otene backbone, we chose the redesigned 4,4′ -diapo-ζ -carotene (pACM-MSA-NzSA) and 4,4′ -diaponeurosporene 
(pACM-MSA-NySA) pathways (Fig. 1). First, expanding upon the redesigned 4,4′ -diaponeurosporene pathway, 
we expressed each C40 CrtY from Salinibacter ruber (CrtYSR), C. glutamicum (CrtYCG), Brevibacterium linens 
(CrtYBL), Pantoea ananatis (CrtYPN), and Pantoea agglomerans (CrtYPA) to investigate their non-natural substrate 
Figure 2. Analysis of C30and C35 acyclic carotenoids produced by engineered E. coli cells. (a) HPLC profiles 
of the C30 acyclic carotenoids pathway reconstructed in E. coli expressing background pACM-MSA and wild-
type and mutant CrtN. (b) HPLC profiles of the C30 carotenoids pathway reconstructed in E. coli expressing 
pACM-MSA-NSA-ARS and CrtDRC. (c) HPLC profiles of the C35 acyclic carotenoid pathway reconstructed in  
E. coli expressing pACM-MSA-NSA and CrtEbGC. UV/Vis absorption spectra for compounds corresponding to 
individual peaks are shown in the upper-right panels. Cell pellets and identified carotenoid structures are shown 
in the lower-right panel.
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promiscuity to form one β -ionone ring in acyclic C30 4,4′ -diaponeurosporene. Among them, CrtYBL and CrtYPA 
produced new HPLC peaks, while the others did not show noticeable differences when compared to control cells 
expressing empty vector (Fig. 3a). Based on combined structural analysis, we speculated that CrtYBL catalyzed 
the cyclization of one saturated end of non-natural substrate 4,4′ -diaponeurosporene, generating structurally 
novel monocyclic C30 4,4′ -diapotorulene (peak 3 in Fig. 3a). To enhance the selectivity toward the monocy-
clic 4,4′ -diapotorulene pathway, CrtYBL was evolved by error-prone PCR and some mutant CrtYtBL enzymes 
showing higher selectivity toward 4,4′ -diapotorulene (Supplementary Fig. 2) were selected for pathway exten-
sion (see next section). Interestingly, unlike the high selectivity of CrtYBL for 4,4′ -diapotorulene, CrtYPA showed 
low specificity toward non-natural short substrates 4,4′ -diaponeurosporene and 4,4′ -diapo-ζ -carotene, and 
low catalytic efficiency. We hypothesized that CrtYPA cyclized each saturated end of the non-natural substrate 
4,4′ -diapo-ζ -carotene and one saturated end of the non-natural substrate 4,4′ -diaponeurosporene, creating bicy-
clic C30 4,4′ -diapo-β -carotene (peak 4 in Fig. 3a) and monocyclic C30 4,4′ -diapotorulene, respectively, albeit at 
very small amounts. Notably, the formation of bicyclic 4,4′ -diapo-β -carotene indicated that CrtYPA had an affin-
ity for 4,4′ -diapo-ζ -carotene, one of pathway intermediates in the redesigned 4,4′ -diaponeurosporene pathway 
(Fig. 1).
Next, to selectively increase bicyclic 4,4′ -diapo-β -carotene production, we coexpressed CrtYBL, CrtYPA, 
and mutant CrtYtBL with the redesigned 4,4′ -diapo-ζ -carotene pathway. As expected from the observed affin-
ity of CrtYPA for 4,4′ -diapo-ζ -carotene, CrtYPA produced 4,4′ -diapo-β -carotene with high selectivity (Fig. 3b). 
Unexpectedly, CrtYBL also produced a small amount of bicyclic 4,4′ -diapo-β -carotene, which was not detected 
upon coexpression with 4,4′ -diaponeurosporene, suggesting that the relative substrate concentration significantly 
Figure 3. Functional comparison of CrtYs from various sources in E. coli expressing the 
4,4′-diaponeurosporene or 4,4′-diapo-ζ-carotene pathway. (a) Each C40 CrtY from a different source was 
coexpressed with the 4,4′ -diaponeurosporene pathway, pACM-MSA-NySA, to compare its activity on the C30 
backbone. (b) In vivo activity of mutant CrtYtBL, wild-type CrtYBL, and CrtYPA on 4,4′ -diapo-ζ -carotene was 
compared in E. coli expressing pACM-MSA-NzSA. UV/Vis absorption spectra for compounds corresponding to 
individual peaks are shown in the upper-right panel. Identified carotenoid structures are shown in the lower-
right panel.
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influences the product profile of CrtYBL. Mutant CrtYtBL produced 4,4′ -diapo-β -carotene and 4,4′ -diapotorulene 
at a similar ratio, indicating that mutant CrtYtBL had a virtually equal substrate affinity for 4,4′ -diapo-ζ -carotene 
and 4,4′ -diaponeurosporene.
Biosynthesis of structurally novel monocyclic C30 carotenoids harboring a modified β-ionone 
ring. Two β -ionone ring moiety-modifying enzymes, C40 carotene ketolase (CrtOSY) from Synechocystis sp. 
PCC 6830 and C40 β -carotene hydroxylase (CrtZPA) from P. agglomerans, were individually coexpressed with 
the 4,4′ -diapotorulene pathway (pACM-MSA-NySA-YtBL) to create structurally novel monocyclic C30 carote-
noids. Combined structural analysis revealed that CrtZPA catalyzed the hydroxylation of the β -ionone ring in 
the non-natural substrate 4,4′ -diapotorulene, creating 7-hydroxy-4,4′ -diapotorulene (peak 4 in Fig. 4a), while 
CrtOSY catalyzed the addition of a ketone group into the β -ionone ring, creating 8-keto-4,4′ -diapotorulene (peak 
3 in Fig. 4a).
The redesigned 7-hydroxy-4,4′ -diapotorulene pathway (pACM-MSA-NySA-YtBL-ZPA) was further extended 
by individually coexpressing C40 carotene ketolase (CrtWNO) from Nostoc sp. PCC 7120 and C40 zeaxan-
thin glucosyltransferase (CrtXPA) from P. agglomerans. The results indicated that CrtXPA catalyzed the glyco-
sylation of the hydroxyl-β -ionone ring in the non-natural substrate 7-hydroxy-4,4′ -diapotorulene, creating 
Figure 4. Analysis of C30 monocyclic carotenoids produced by engineered E. coli cells. (a) HPLC profiles of 
the C30 monocyclic carotenoids pathway reconstructed in E. coli expressing background pACM-MSA-NySA-YtBL 
or pACM-MSA-NySA-YtBL-ZPA and C40 carotenoid modifying enzymes (CrtXPA, CrtWNO, CrtZPA and CrtOSY).  
(b) HPLC profiles of the C30 monocyclic carotenoids pathways reconstructed in E. coli expressing pACM-MSA-
NSA-PSA with CrtYtBL and AldHSA. UV/Vis absorption spectra for compounds corresponding to individual peaks 
are shown in the upper-right panels. Identified carotenoid structures are shown in the lower-right panels.
www.nature.com/scientificreports/
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7-hydroxy-4,4′ -diapotorulene glucoside (peak 6 in Fig. 4a), while CrtWNO catalyzed the addition of a ketone 
group into the hydroxyl-β -ionone ring, creating 7-hydroxy-8-keto-4,4′ -diapotorulene (peak 5 in Fig. 4a).
Biosynthesis of structurally novel monocyclic C30 carotenoids with a modified acyclic 
end. Next, we aimed to create novel monocyclic C30 carotenoid structures by modifying the acyclic end of 
the carotene backbone. We first coexpressed C30 4,4′ -diaponeurosporene oxidase (CrtPSA) from S. aureus32 
with the redesigned 4,4′ -diapotorulene pathway. As expected from the reported low specificity of CrtPSA32, 
novel C30 4,4′ -diapotorulen-4′ -al (peak 8 in Fig. 4b) was produced, and 4,4′ -diaponeurosporen-4′ -al accu-
mulated (peak 7 in Fig. 4b). Notably, CrtPSA could compete with YtBL for 4,4′ -diaponeurosporene substrate for 
the production of 4,4′ -diaponeurosporen-4′ -al and 4,4′ -diapotorulene, respectively, which were further modi-
fied by the other competing enzymes. The reaction sequence for 4,4′ -diapotorulen-4′ -al production is unclear, 
but based on the fact that 4,4′ -diapotorulene was not detectable on HPLC, we postulate that YtBL would first 
produce 4,4′ -diapotorulene, to which an aldehyde group was added by CrtPSA, resulting in the formation of 
4,4′ -diapotorulen-4′ -al.
For further extension of the redesigned 4,4′ -diapotorulen-4′ -al pathway (pACM-MSA-NySA-PSA+pUCM-YtBL), 
C30 4,4′ -diaponeurosporene aldehyde dehydrogenase (AldHSA) from S. aureus32 was expressed. The results sug-
gested that AldHSA catalyzed the oxidation of non-natural substrate 4,4′ -diapotorulen-4′ -al, creating novel C30 
4,4′ -diapotorulen-4′ -oic acid (peak 10 in Fig. 4b). These novel monocyclic C30 structures could be used as sub-
strates for carotenoid cleavage dioxygenases for the production of novel apocarotenoids33. 1H NMR analysis of 
4,4′ -diapotorulene was performed to provide structural evidence of 4,4′ -diapotorulene derivatives produced in 
E. coli (Supplementary Fig. 3).
Biosynthesis of structurally novel bicyclic C30 carotenoids. Next, we attempted to extend the 
bicyclic C30 4,4′ -diapo-β -carotene pathway. Similar to the extension of the monocyclic 4,4′ -diapotorulene 
pathway, we individually coexpressed C40 CrtOSY and CrtZPA with the redesigned 4,4′ -diapo-β -carotene 
pathway (pACM-MSA-NzSA-YPA). Combined structural analysis indicated that CrtZPA catalyzed the hydrox-
ylation of the β -ionone ring at each end of the non-natural substrate 4,4′ -diapo-β -carotene, creating C30 
4,4′ -diapo-β -cryptoxanthin (peak 5 in Fig. 5a) through one-step hydroxylation, and a very tiny amount of C30 
4,4′ -diapozeaxanthin (peak 6 in Fig. 5a) through two-step hydroxylation. Unlike the two-step reactions of CrtZPA 
on the two β -ionone rings, CrtOSY only catalyzed one addition of a ketone group into one β -ionone ring in the 
non-natural substrate 4,4′ -diapo-β -carotene, creating C30 4,4′ -diapoechinenone (peak 7 in Fig, 5a). The detection 
of a tiny amount of 4,4′ -diapozeaxanthin and the absence of the expected structure 4,4′ -diapocanthaxanthin 
suggested that the catalytic activity of C40 carotenoid-modifying enzymes towards the non-natural short substrate 
4,4′ -diapo-β -carotene was lower than that towards the other non-natural short substrate 4,4′ -diapotorulene.
Finally, we coexpressed C40 CrtXPA with the redesigned 4,4′ -diapo-β -cryptoxanthin pathway 
(pACM-MSA-NzSA-YtBL-ZPA). On the basis of combined structural analysis, we hypothesized that CrtXPA catalyzed 
Figure 5. Analysis of C30 bicyclic carotenoids produced by engineered E. coli cells. (a) HPLC profiles of the 
C30 bicyclic carotenoids pathway reconstructed in E. coli expressing background pACM-MSA-NzSA-YPA and C40 
carotenoid modifying enzymes (CrtOSY and CrtZPA). Insets: absorption spectra for individual peaks. (b) HPLC 
profiles of the C30 bicyclic carotenoids pathway reconstructed in E. coli expressing pACM-MSA-NzSA-YPA-ZPA 
and CrtXPA. UV/Vis absorption spectra for compounds corresponding to individual peaks are shown in the 
middle panels. Identified carotenoid structures are shown in the right panels.
www.nature.com/scientificreports/
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the glycosylation of a hydroxyl-β -ionone ring in the non-natural substrate 4,4′ -diapo-β -cryptoxanthin, creating 
C30 4,4′ -diapo-β -cryptoxanthin glucoside (peak 8 in Fig. 5b).
Taken together, we created 14 structurally novel carotenoids in recombinant E. coli; their mass spectra are 
shown in Supplementary Fig. 4.
Radical scavenging activity of structurally novel C30 carotenoids. Most carotenoids typically have 
antioxidative activity13. Recently, carotenoids are gaining considerable research attention, along with the increas-
ing interest in the role of dietary phytochemicals in human health34. While antioxidative activities of natural C40 
carotenoids have been well analyzed, C30 carotenoids have been hardly studied because they are rare in nature and 
are absent in plants. Therefore, we investigated the radical scavenging activity of five purified, novel C30 carote-
noids, including acyclic, monocyclic, and bicyclic structures, as well as two previously reported C30 carotenoids 
(4,4′ -diapolycopene and 4,4′ -diaponeurosporene) using the DPPH free radical method35,36. DL-α -tocopherol 
was included as a control compound37. Scavenging reactions were found to be optimal when molar ratios of carot-
enoid:DPPH between 1:10 and 1:20 were used (data not shown). As expected from the reported antioxidant activ-
ities of various C40 carotenoid structures, C30 carotenoids containing higher numbers of CDBs tended to exhibit 
higher radical scavenging activity than those with fewer CDBs (Fig. 6a), e.g., 4,4′ -diapolycopene (13 CDBs) vs. 
4,4′ -diaponeurosporene (11 CDBs). Notably, 4,4′ -diapolycopene-4,4′ -dial (13 CDBs+ 2 aldehyde groups) was the 
most efficient scavenger, followed by 4,4′ -diapolycopene (13 CDBs), 4,4′ -diaponeurosporenoic acid (11 CDBs+ 1 
carboxylic group), 4,4′ -diaponeurosporenoic acid (11 CDBs+ 1 aldehyde group), and 4,4′ -diaponeurosporene 
(11 CDBs) (Table 1). Cyclic C30 carotenoids, 4,4′ -diapotorulene and 4,4′ -diapo-β -carotene, showed lower anti-
oxidative activity than acyclic C30 carotenoids, and even lower than the antioxidant control DL-α -tocopherol 
(Fig. 6a, Table 1). Collectively, the number of CDBs seemed to be one of the most important factors influencing 
the antioxidative activity of C30 carotenoids, and C30 carotenoids having a carboxyl group at the end of the back-
bone had slightly higher antioxidative activities than those with the same number of CDBs but with an aldehyde 
end group.
Neuronal differentiation activity of structurally novel C30 carotenoid 4,4′-diapotorulene. 
Retinoic acid, an important signaling molecule, has been extensively investigated for its role in inducing neuronal 
differentiation from various progenitor cells38,39. Because 4,4′ -diapotorulen-4′ -oic acid is structurally similar to 
retinoic acid, we assumed that it would also have similar biological activity. However, since the amount of purified 
4,4′ -diapotorulen-4′ -oic acid produced by recombinant E. coli was not sufficient for neuronal differentiation and 
cytotoxicity assays, 4,4′ -diapotorulene was selected for the neuronal differentiation assay in rat bone marrow 
mesenchymal stem cells (rBMSCs)40.
Cytotoxicity of 4,4′ -diapotorulene in the rBMSCs was dose-dependent, and approximately 20% of the 
cells were died after 7 days of treatment with the highest concentration (50 μ M) of 4,4′ -diapotorulene as com-
pared to control cells (Supplementary Fig. 5). When rBMSCs were treated with varying concentrations of 
Figure 6. Comparison of DPPH scavenging activity of various C30 carotenoids and morphological changes 
of rBMSCs treated with varying concentrations of 4,4′-diapotorulene for 7 days. (a) DL-α -tocopherol was 
used as a control antioxidant. Values are represented as the mean ± SD from three independent experiments. 
(b) Cells were treated with varying concentrations of 4,4′ -diapotorulene and observed under the microscope for 
7 days. Scale bar represents 50 μ m.
www.nature.com/scientificreports/
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4,4′ -diapotorulene (2, 10, 20, and 50 μ M), rBMSCs exhibited bipolar/multipolar or web-shaped morphology 
characteristic of neuronal cells after a 24-h treatment (Fig. 6b). With longer incubation time (4 and 7 days), the 
morphological changes enhanced in a dose-dependent manner. These findings indicated the potential neuronal 
differentiation activity of monocyclic C30 4,4′ -diapotorulene on rBMSCs.
Discussion
Metabolic engineering enables the creation of non-natural pathways for novel structures of biotechnological 
importance, especially by exploiting the promiscuity of biosynthetic pathway enzymes and directed evolution41–44. 
Recent research interest in phytochemicals has consistently driven the efforts in the metabolic engineering field 
toward microbial production of various isoprenoids. In spite of systematic studies on the microbial production of 
carotenoids, similar to other isoprenoids such as terpenoids, the possibility of using C30 carotenoids, which have 
not been reported in plant sources, as biologically functional compounds has not been explored thus far. Our 
study sheds light on the generation of a new series of short C30 carotenoid structures as well as on their poten-
tial biological properties such as radical scavenging activity and neuronal differentiation activity. Carotenoids 
including apo-carotenoids are well known as antioxidative compounds, also interested by their other beneficial 
biological activities including anticancer activity17. Even though some studies have been made to understand 
relationship between structure of carotenoids and their anticancer effect, still there is a lack of knowledge on how 
carotenoids are transferred and modified into apo-carotenoids in the cell45,46. Nevertheless, it is known that com-
plex structures of carotenoids with longer CDBs and/or more functional groups show higher antioxidant activity, 
which was consistent with our radical scavenging assay (Fig. 6a). Microbial production of apo-carotenoids of 
biotechnological interest using carotenoid cleavage enzymes is not promising due to low yield and productivity33. 
Thus, our strategy to produce short C30 carotene-aldehyde/acid derivatives can be served as an alternative method 
without employing carotenoid cleavage enzymes. Furthermore, as 4,4′ -diapotorulene showed neuronal differen-
tiation activity (Fig. 6b) like retinoic acid, an important apo-carotenoid in cell development38, 4,4′ -diapotorulene 
derivatives could open new opportunities for developing bioactive compounds.
Directed evolution of enzymes in early steps in the biosynthesis pathway and combinatorial biosynthesis 
is a powerful tool for generating diverse novel structures in microbes as described in Introduction section. In 
this study, CrtN was evolved to optimize 4,4′ -diaponeurosporene or 4,4′ -diapo-ζ -carotene biosynthesis path-
way (Fig. 2a), which could be cyclized into non-natural cyclic C30 carotenoids. Directed evolution of CrtY from 
B. linens successfully drove cyclization reaction of 4,4′ -diaponeurosporene into 4,4′ -diapotorulene (Fig. 3a). 
Through combinatorial biosynthesis by using different CrtY enzymes47, we achieved selective production of 
4,4′ -diapo-β -carotene from 4,4′ -diapo-ζ -carotene (Fig. 3b). After we selectively optimized C30 carotenoid bio-
synthetic pathways using mutant CrtN and CrtY enzymes, combinatorial biosynthesis with diverse C40 and C50 
carotenoid-modifying enzymes found in nature (Supplementary Fig. 6) yielded one acyclic C35 carotenoid and 
two acyclic, six monocyclic, and five bicyclic C30 carotenoids in recombinant E. coli (Fig. 1). Because new types 
of carotenoid enzymes including carotenoid cleavage enzymes, which can produce biologically more functional 
apo-carotenoids are continually being discovered and characterized, more structurally novel C30 carotenoids 
could be generated by using our strategies in the near future, as we had shown in the previous report33. The 
expanding pool of structurally novel short carotenoids will open up the possibilities for discovery of bioactive 
compounds, which are potential candidates for drug development and cosmetic applications. However, since this 
is the first report on the generation of novel C30 and C35 carotenoid structures, more detailed and comprehensive 
investigation of the biological and physiological activity of C30 carotenoids is warranted. To address this, more 
quantitative and systems-level studies are needed to selectively direct the metabolic flux towards the formation of 
novel structures and increase titer of these novel structures in E. coli. Finally, we believe that this work can serve as 
a basis for investigators handling various carotenoids as candidates of biological active compounds in cosmetics, 
pharmaceutical, feeds, and fine chemical industries.
Materials and Methods
Bacterial strains, plasmids, and growth conditions. The bacterial strains and plasmids used in this 
study are listed in Supplementary Table 1. For gene cloning, the E. coli XL1-Blue strain was grown at 37 °C in 
Luria-Bertani (LB) medium on a rotary shaker at 250 rpm. For carotenoid production, the E. coli SURE strain29 
No. of 
conjugated 
double bonds
Functional 
group
DPPH 
IC50 (μM)
Diapolycopene 11 – 8.7
Diaponeurosporene 9 – 11.6
Diaponeurosporen-al 10 1 aldehyde 10.2
Diapolycopen-dial 13 2 aldehydes 7.5
Diaponeurosporenoic acid 10 1 carboxyl 9.7
Diapotorulene 8+ 1* – 70.3
Diapo-β -carotene 5+ 2* – 77.8
DL-α -tocopherol – – 33.2
Table 1.  Half-maximal effective concentration (IC50) values of C30 carotenoids towards DPPH. *Additional 
double bond within the β -end group.
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was grown at 30 °C in Terrific Broth (TB) medium on a rotary shaker at 250 rpm, except for pBBR-aldHSA, which 
was expressed in XL1-Blue because of kanamycin resistance of the SURE strain. Chloramphenicol (50 μ g/mL), 
ampicillin (100 μ g/mL), and/or kanamycin (30 μ g/mL) (Sigma) were added as required. P. agglomerans KCTC 
2479, R. capsulatus KCTC 2583, and C. glutamicum KCTC 1445 were cultivated in LB medium at 30 °C on a 
rotary shaker at 250 rpm. S. ruber DSMZ 13855 was grown in medium consisting of 195 g of NaCl, 34.6 g of 
MgCl2, 49.5 g of MgSO4, 1.25 g of CaCl2, 5 g of KCl, 0.25 g of NaHCO3, 0.625 g of NaBr, and 0.1 g of yeast extract 
per 1 L of double-distilled water at 37 °C for 7 days.
Gene cloning and construction of C30 carotenogenic gene modules. The genes crtY (encoding lyco-
pene cyclase), crtX (glucosyltransferase), and crtD (carotene 3,4-desaturase) were PCR-amplified from genomic 
DNA of S. ruber, P. agglomerans KCTC 2479, and R. capsulatus KCTC 2583, respectively, using gene-specific 
primers (Supplementary Table 2). The crtEb (lycopene elongase) and crtY (carotene cyclase) genes were ampli-
fied from C. glutamicum KCTC 1445 genomic DNA using gene-specific primers. The PCR products were cloned 
into pUCM vector29, resulting in pUCM-XAB (where pUCM indicates the vector used, X represents the gene 
name, and the subscript AB in X represents the gene source microorganism; see Supplementary Table1). C30 
carotenogenic gene modules were constructed as described previously32. Briefly, a gene was subcloned from 
pUCM-XAB into pACYC184 by amplifying the gene together with a modified constitutive lac-promoter, resulting 
in pACM-XAB (note: sequential assembly of a gene YAB into a module results in pACM-XAB-YAB, for example). 
PCR amplification was carried out using a DNA Engine Thermal Cycler (Bio-Rad; Hercules, CA, USA) with Vent 
polymerase (New England Biolabs; Beverly, MA, USA) for cloning, with Taq polymerase (Intron Biotechnology; 
Seoul, Korea) for random mutagenesis, and, with pfuUltra II fusion polymerase (Agilent Technologies; Palo Alto, 
CA, USA) for site-directed mutagenesis. Restriction enzymes and T4 DNA ligase were all purchased from New 
England Biolabs.
Directed evolution of CrtN and CrtY. A mutant library was constructed by error-prone PCR with Taq pol-
ymerase by increasing the MgCl2 concentration (up to 2.5 mM) and altering the dNTP ratio (ATP:TTP:CTP:GTP, 
1:1:1:4). Error-prone PCR of crtN or crtY in pUCM was carried out under error-prone conditions with 
plasmid-specific PCR primers (5′ -CCGACTGGAAAGCG-3′ and 5′ -CGGTGTGAAATACCG-3′ ) flanking the 
gene and promoter. The PCR products of crtN and crtY were cloned into the pUCM vector and electrotrans-
formed into recombinant E. coli XL1-Blue harboring pACM-MSA and pACM-MSA-NSA, respectively. Colonies 
were screened visually on agar plates for color variants after 24 h of incubation (or until color developed) at room 
temperature. Selected colonies were aerobically grown in TB (4 mL) overnight, pelleted, and repeatedly extracted 
with 2–4 mL acetone. Thin-layer chromatography (TLC) was carried out using a 100% hexane solvent system for 
initial screening of positive mutant clones. For discrimination of false positive clones, plasmids having mutant 
a gene were isolated from positive clones and then retransformed into fresh competent E. coli cells harboring 
pACM-MSA or pACM-MSA-NSA. Sequences of selected crtN and crtY clones were confirmed by Sanger sequenc-
ing (Macrogen; Seoul, Korea).
Isolation of carotenoids. Cells were pelleted by centrifugation (4 °C, 4000 rpm), and carotenoids were 
repeatedly extracted from the pellets with 15 mL acetone until all visible pigments were removed from the pellets. 
The colored supernatants were pooled after centrifugation (4 °C, 4000 rpm) and concentrated to 5–10 mL using 
an EZ-2 Plus centrifugal evaporator (Genevac Inc.; Vally Center, NY, USA). An equal volume of ethyl acetate 
(EtOAc) was added to the concentrated solution that was re-extracted after adding an equal volume of 5 N NaCl 
solution for salting out. The upper phase, containing the carotenoids, was collected, washed with distilled water, 
passed through a sodium sulfate column (anhydrous, Bio Basic Inc; ON, Canada), and completely dried using the 
EZ-2 Plus evaporator. The dried samples were stored at − 80 °C until further use.
For purification, the isolated carotenoids were dissolved in 0.2 mL of EtOAc, filtered (0.45-μ m GHP mem-
brane, Pall Corporation; NY, USA), and loaded onto a silica gel column, which was pre-equilibrated with a 100% 
hexane or a 9:1 hexane/EtOAc solvent system. Carotenoids were eluted using the same solvent system with an 
increasing gradient of EtOAc. Each of the eluted carotenoids was concentrated into a small volume, loaded onto 
a TLC silica gel plate (Merck Millipore, Billerica, MA, USA), and developed with solvent systems comprising 
hexane/EtOAc (9:1, v/v) or hexane/EtOAc/methanol (9:1:3, v/v/v). Each carotenoid band was scraped from the 
TLC plate, followed by elution with methanol. Glassware was used for each step, and stray light was blocked 
with aluminum foil. Purified C30 carotenoids were quantified using a spectrophotometer (SpectraMax Plus384, 
Molecular Devices; CA, USA) by comparison with the extinction coefficient of known, similar structures of C40 
carotenoids48.
Structural analysis of carotenoids. An aliquot (10–20 μ L) of the collected fraction or crude extracts 
was applied to a ZORBAX Eclipse XDB-C18 column (4.6 mm × 150 mm or 4.6 mm × 250 mm, 5.0 μ m; Agilent 
Technologies; Santa Clara, USA) and eluted under isocratic conditions with a solvent system (acetonitrile:meth-
anol:isopropanol, 80:15:5) at a flow rate of 1 mL/min using an Agilent 1200 HPLC system equipped with a pho-
todiode array detector (Agilent Technologies). Chromatograms were recorded at wavelengths of 470, 440, and 
400 nm to trace the elution of linear, monocyclic, and bicyclic C30 carotenoids, respectively. The mass fragmenta-
tion spectra were monitored using both negative and positive ion modes in the mass range of m/z 200 to 600 on a 
liquid chromatography–mass spectrometer (LC/MS; Agilent 6150) equipped with an atmospheric pressure chem-
ical ionization ion source (Agilent Technologies). The HPLC retention times, UV/Vis absorption spectra, and 
mass fragmentation spectra were all combined for the structural identification of the C30 carotenoids. For NMR 
analysis of 4,4′ -diapotorulene, purified 4,4′ -diapotorulene was dissolved in CD3OD and the 1H NMR (600 MHz) 
spectra were recorded on a Bruker Avance 600 system.
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DPPH radical scavenging assay. The 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging assay for 
purified C30 carotenoids was performed as described previously37 with a minor modification. Buffered methanol 
was prepared by mixing 40 mL of 0.1 M acetate solution (pH 5.5) with 60 mL of methanol. Assays were initiated by 
adding 250 μ L of 0.2 M DPPH solution into 200 μ L of buffered methanol containing 50 μ L of 100 μ M carotenoid, 
and incubated in the dark for 1 h. The absorbance at 517 nm was measured using a UV/Vis spectrophotometer 
(SpectraMax Plus384) against a blank consisting of the reaction mixture without DPPH. dl-α -tocopherol was 
included as a control. Experiments were performed in triplicate and the data are presented as mean ± standard 
deviation (SD). IC50 values were calculated after curves were fitted using SigmaPlot 11.0.
Cytotoxicity tests and neurogenesis of rBMSCs. 4,4′ -Diapotorulene was dissolved in DMSO at a con-
centration of 100 mM and diluted in culture medium to obtain the desired concentrations (2, 5, 10, and 50 μ M). 
The final concentration of DMSO was kept below 0.02% to maximally eliminate the effect of DMSO. Control 
cells were incubated in the presence of 0.02% DMSO to compare the effect of 4,4′ -diapotorulene. rBMSCs49 
were seeded in a 48-well plate at a density of 3 × 103 cells/well in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS), 100 units/mL penicillin, and 100 μ g/mL streptomycin. After 
incubation for 24 h, the culture media were replaced with fresh DMEM supplemented with 10 ng/mL basic fibro-
blast growth factor and 20% FBS and further incubated overnight. Then, the media were replaced with induction 
media containing 4,4′ -diapotorulene. 4,4′ -Diapotorulene solution was prepared at concentrations of 2, 5, and 
10 μ M in culture medium. For controls, three wells were treated with culture media. At 1, 4, and 7 days, the via-
bility of rBMSCs in the induction media was determined by using MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide], which was converted to formazan that accumulated in the cytoplasm of viable rBMSCs. 
The viability of rBMSCs was tested in three plates individually and the optical density of each well was deter-
mined at 590 nm using a plate reader (E-max, Molecular Device, USA). All experiments were performed at least 
three times and the results are presented as mean ± SD. To detect neuronal differentiation, digital images of the 
rBMSCs in the induction media containing 4,4′ -diapotorulene were captured using an inverted phase-contrast 
microscope at 1, 4, and 7 days of incubation.
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